Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,039 | 43 | 85.1% |
| Education | $182.11 | 5 | 14.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $505.64 | 19 | $0 (2024) |
| Horizon Therapeutics plc | $207.25 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $137.25 | 4 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $129.75 | 4 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $120.48 | 1 | $0 (2019) |
| Allergan Inc. | $61.88 | 5 | $0 (2017) |
| Exeltis, USA Inc. | $17.36 | 1 | $0 (2022) |
| Gilead Sciences Inc | $15.08 | 1 | $0 (2017) |
| Travere Therapeutics, Inc. | $14.23 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $12.06 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.04 | 6 | Mallinckrodt Hospital Products Inc. ($75.92) |
| 2023 | $163.74 | 4 | Mallinckrodt Hospital Products Inc. ($163.74) |
| 2022 | $449.36 | 19 | Mallinckrodt Hospital Products Inc. ($218.64) |
| 2021 | $184.59 | 7 | GlaxoSmithKline, LLC. ($137.25) |
| 2020 | $12.06 | 1 | AstraZeneca Pharmaceuticals LP ($12.06) |
| 2019 | $215.47 | 2 | OPKO Pharmaceuticals, LLC ($120.48) |
| 2017 | $111.72 | 9 | Allergan Inc. ($61.88) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 04/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $79.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: KRYSTEXXA | ||||||
| 10/06/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: KRYSTEXXA | ||||||
| 09/22/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: KRYSTEXXA | ||||||
| 09/15/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: KRYSTEXXA | ||||||
| 08/25/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: KRYSTEXXA | ||||||
| 08/16/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $6.11 | General |
| 08/11/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: KRYSTEXXA | ||||||
| 08/01/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 07/22/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: KRYSTEXXA | ||||||
| 07/01/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: KRYSTEXXA | ||||||
| 06/23/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $92.55 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 198 | 902 | $133,650 | $58,211 |
| 2022 | 4 | 266 | 1,389 | $198,325 | $90,707 |
| 2021 | 7 | 407 | 2,085 | $298,810 | $140,263 |
| 2020 | 8 | 481 | 2,408 | $371,220 | $162,159 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 677 | $82,000 | $41,554 | 50.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 92 | $18,400 | $9,288 | 50.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 24 | 133 | $33,250 | $7,368 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 125 | 1,012 | $108,925 | $56,372 | 51.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 78 | $19,500 | $12,577 | 64.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 38 | 202 | $50,500 | $11,519 | 22.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 92 | 97 | $19,400 | $10,239 | 52.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 170 | 1,478 | $150,600 | $83,980 | 55.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 52 | 319 | $79,750 | $18,496 | 23.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 130 | 140 | $28,000 | $14,902 | 53.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 41 | $18,450 | $9,725 | 52.7% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 15 | 63 | $15,750 | $9,587 | 60.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 18 | $4,590 | $2,833 | 61.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 26 | $1,670 | $739.78 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 188 | 1,508 | $151,900 | $82,510 | 54.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 62 | 426 | $106,500 | $23,920 | 22.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 18 | 104 | $46,800 | $18,929 | 40.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 111 | 135 | $27,000 | $14,158 | 52.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 60 | $15,300 | $9,236 | 60.4% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 20 | 53 | $13,250 | $7,459 | 56.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 46 | $6,010 | $3,664 | 61.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 28 | 76 | $4,460 | $2,282 | 51.2% |
About Dr. Qing Chen, MD
Dr. Qing Chen, MD is a Nephrology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164494530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qing Chen, MD has received a total of $1,221 in payments from pharmaceutical and medical device companies, with $84.04 received in 2024. These payments were reported across 48 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,039).
As a Medicare-enrolled provider, Chen has provided services to 1,352 Medicare beneficiaries, totaling 6,784 services with total Medicare billing of $451,339. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Saint Louis, MO
- Active Since 02/01/2006
- Last Updated 08/08/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1164494530
Products in Payments
- ACTHAR (Biological) $635.39
- KRYSTEXXA (Biological) $207.25
- BENLYSTA (Biological) $137.25
- Rayaldee (Drug) $120.48
- BYSTOLIC (Drug) $29.23
- VRAYLAR (Drug) $22.18
- PURIFIED CORTROPHIN GEL (Drug) $17.36
- LOKELMA (Drug) $12.06
- SAPHRIS (Drug) $10.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Saint Louis
Dr. Marcos Rothstein, Md, MD
Nephrology — Payments: $771,005
Dr. Daniel Coyne, Md, MD
Nephrology — Payments: $322,158
Dr. Tarek Alhamad, Md, MD
Nephrology — Payments: $237,080
Dr. Anuja Java, Md, MD
Nephrology — Payments: $162,504
Krista Lentine, Md,Phd, MD,PHD
Nephrology — Payments: $90,028
Dr. Tingting Li, Md, MD
Nephrology — Payments: $61,262